ID   CHSTE_HUMAN             Reviewed;         376 AA.
AC   Q8NCH0; Q6PJ31; Q6UXA0; Q96P94;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 2.
DT   10-MAY-2017, entry version 120.
DE   RecName: Full=Carbohydrate sulfotransferase 14;
DE            EC=2.8.2.35;
DE   AltName: Full=Dermatan 4-sulfotransferase 1;
DE            Short=D4ST-1;
DE            Short=hD4ST1;
GN   Name=CHST14; Synonyms=D4ST1; ORFNames=UNQ1925/PRO4400;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ENZYME ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=11470797; DOI=10.1074/jbc.M105848200;
RA   Evers M.R., Xia G., Kang H.-G., Schachner M., Baenziger J.U.;
RT   "Molecular cloning and characterization of a dermatan-specific N-
RT   acetylgalactosamine 4-O-sulfotransferase.";
RL   J. Biol. Chem. 276:36344-36353(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBSTRATE SPECIFICITY.
RX   PubMed=12847091; DOI=10.1074/jbc.M306044200;
RA   Mikami T., Mizumoto S., Kago N., Kitagawa H., Sugahara K.;
RT   "Specificities of three distinct human chondroitin/dermatan N-
RT   acetylgalactosamine 4-O-sulfotransferases demonstrated using partially
RT   desulfated dermatan sulfate as an acceptor. Implication of
RT   differential roles in dermatan sulfate biosynthesis.";
RL   J. Biol. Chem. 278:36115-36127(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hiraoka N., Fukuda M.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 36-376.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [7]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=19661164; DOI=10.1093/glycob/cwp110;
RA   Pacheco B., Maccarana M., Malmstrom A.;
RT   "Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of
RT   iduronic acid blocks in dermatan sulfate.";
RL   Glycobiology 19:1197-1203(2009).
RN   [8]
RP   INVOLVEMENT IN EDSMC1.
RX   PubMed=20842734; DOI=10.1002/humu.21355;
RA   Malfait F., Syx D., Vlummens P., Symoens S., Nampoothiri S.,
RA   Hermanns-Le T., Van Laer L., De Paepe A.;
RT   "Musculocontractural Ehlers-Danlos syndrome (former EDS type VIB) and
RT   adducted thumb clubfoot syndrome (ATCS) represent a single clinical
RT   entity caused by mutations in the dermatan-4-sulfotransferase 1
RT   encoding CHST14 gene.";
RL   Hum. Mutat. 31:1233-1239(2010).
RN   [9]
RP   VARIANTS EDSMC1 GLY-135; GLN-137; PRO-213 AND CYS-293, AND
RP   CHARACTERIZATION OF VARIANTS EDSMC1 GLY-135; GLN-137; PRO-213 AND
RP   CYS-293.
RX   PubMed=20004762; DOI=10.1016/j.ajhg.2009.11.010;
RA   Dundar M., Muller T., Zhang Q., Pan J., Steinmann B., Vodopiutz J.,
RA   Gruber R., Sonoda T., Krabichler B., Utermann G., Baenziger J.U.,
RA   Zhang L., Janecke A.R.;
RT   "Loss of dermatan-4-sulfotransferase 1 function results in adducted
RT   thumb-clubfoot syndrome.";
RL   Am. J. Hum. Genet. 85:873-882(2009).
RN   [10]
RP   VARIANTS EDSMC1 LEU-281; SER-289 AND CYS-293, AND CHARACTERIZATION OF
RP   VARIANTS EDSMC1 LEU-281; SER-289 AND CYS-293.
RX   PubMed=20533528; DOI=10.1002/humu.21300;
RA   Miyake N., Kosho T., Mizumoto S., Furuichi T., Hatamochi A.,
RA   Nagashima Y., Arai E., Takahashi K., Kawamura R., Wakui K.,
RA   Takahashi J., Kato H., Yasui H., Ishida T., Ohashi H., Nishimura G.,
RA   Shiina M., Saitsu H., Tsurusaki Y., Doi H., Fukushima Y., Ikegawa S.,
RA   Yamada S., Sugahara K., Matsumoto N.;
RT   "Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos
RT   syndrome.";
RL   Hum. Mutat. 31:966-974(2010).
CC   -!- FUNCTION: Catalyzes the transfer of sulfate to position 4 of the
CC       N-acetylgalactosamine (GalNAc) residue of dermatan sulfate. Plays
CC       a pivotal role in the formation of 4-0-sulfated IdoA blocks in
CC       dermatan sulfate. Transfers sulfate to the C-4 hydroxyl of
CC       beta1,4-linked GalNAc that is substituted with an alpha-linked
CC       iduronic acid (IdoUA) at the C-3 hydroxyl. Transfers sulfate more
CC       efficiently to GalNAc residues in -IdoUA-GalNAc-IdoUA- than in
CC       -GlcUA-GalNAc-GlcUA-sequences. Has preference for partially
CC       desulfated dermatan sulfate. Addition of sulfate to GalNAc may
CC       occur immediately after epimerization of GlcUA to IdoUA. Appears
CC       to have an important role in the formation of the cerebellar
CC       neural network during postnatal brain development.
CC       {ECO:0000269|PubMed:19661164}.
CC   -!- CATALYTIC ACTIVITY: 3'-phospho-5'-adenylyl sulfate + [dermatan]-N-
CC       acetyl-D-galactosamine = adenosine 3',5'-bisphosphate +
CC       [dermatan]- 4-O-sulfo-N-acetyl-D-galactosamine.
CC       {ECO:0000269|PubMed:11470797, ECO:0000269|PubMed:19661164}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at high level in
CC       pituitary gland, placenta, uterus and thyroid.
CC       {ECO:0000269|PubMed:11470797}.
CC   -!- DISEASE: Ehlers-Danlos syndrome, musculocontractural type 1
CC       (EDSMC1) [MIM:601776]: A form of Ehlers-Danlos syndrome
CC       characterized by distinctive craniofacial dysmorphism, congenital
CC       contractures of thumbs and fingers, clubfeet, severe
CC       kyphoscoliosis, muscular hypotonia, hyperextensible thin skin with
CC       easy bruisability and atrophic scarring, wrinkled palms, joint
CC       hypermobility, and ocular involvement.
CC       {ECO:0000269|PubMed:20004762, ECO:0000269|PubMed:20533528,
CC       ECO:0000269|PubMed:20842734}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 2 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ88811.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF401222; AAK92532.1; -; mRNA.
DR   EMBL; AB066595; BAB84097.1; -; mRNA.
DR   EMBL; AF282905; AAK69530.1; -; mRNA.
DR   EMBL; AK074739; BAC11172.1; -; mRNA.
DR   EMBL; BC023653; AAH23653.1; -; mRNA.
DR   EMBL; BC049214; AAH49214.1; -; mRNA.
DR   EMBL; BC053633; AAH53633.1; -; mRNA.
DR   EMBL; AY358446; AAQ88811.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10059.1; -.
DR   RefSeq; NP_569735.1; NM_130468.3.
DR   UniGene; Hs.442449; -.
DR   ProteinModelPortal; Q8NCH0; -.
DR   BioGrid; 125232; 5.
DR   STRING; 9606.ENSP00000307297; -.
DR   iPTMnet; Q8NCH0; -.
DR   PhosphoSitePlus; Q8NCH0; -.
DR   BioMuta; CHST14; -.
DR   DMDM; 61211839; -.
DR   EPD; Q8NCH0; -.
DR   MaxQB; Q8NCH0; -.
DR   PaxDb; Q8NCH0; -.
DR   PeptideAtlas; Q8NCH0; -.
DR   PRIDE; Q8NCH0; -.
DR   DNASU; 113189; -.
DR   Ensembl; ENST00000306243; ENSP00000307297; ENSG00000169105.
DR   GeneID; 113189; -.
DR   KEGG; hsa:113189; -.
DR   UCSC; uc001zlw.4; human.
DR   CTD; 113189; -.
DR   DisGeNET; 113189; -.
DR   GeneCards; CHST14; -.
DR   HGNC; HGNC:24464; CHST14.
DR   HPA; HPA057697; -.
DR   HPA; HPA071601; -.
DR   MalaCards; CHST14; -.
DR   MIM; 601776; phenotype.
DR   MIM; 608429; gene.
DR   neXtProt; NX_Q8NCH0; -.
DR   OpenTargets; ENSG00000169105; -.
DR   Orphanet; 2953; Ehlers-Danlos syndrome, musculocontractural type.
DR   PharmGKB; PA162382258; -.
DR   eggNOG; KOG4651; Eukaryota.
DR   eggNOG; ENOG4111GJR; LUCA.
DR   GeneTree; ENSGT00760000119214; -.
DR   HOGENOM; HOG000231801; -.
DR   HOVERGEN; HBG050954; -.
DR   InParanoid; Q8NCH0; -.
DR   KO; K08105; -.
DR   OMA; MFPRPLT; -.
DR   OrthoDB; EOG091G0FZO; -.
DR   PhylomeDB; Q8NCH0; -.
DR   TreeFam; TF325581; -.
DR   BioCyc; MetaCyc:ENSG00000169105-MONOMER; -.
DR   BRENDA; 2.8.2.35; 2681.
DR   Reactome; R-HSA-2022923; Dermatan sulfate biosynthesis.
DR   ChiTaRS; CHST14; human.
DR   GeneWiki; CHST14; -.
DR   GenomeRNAi; 113189; -.
DR   PRO; PR:Q8NCH0; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000169105; -.
DR   CleanEx; HS_CHST14; -.
DR   ExpressionAtlas; Q8NCH0; baseline and differential.
DR   Genevisible; Q8NCH0; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0042301; F:phosphate ion binding; NAS:UniProtKB.
DR   GO; GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro.
DR   GO; GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome.
DR   GO; GO:0050655; P:dermatan sulfate proteoglycan metabolic process; IDA:UniProtKB.
DR   InterPro; IPR018011; Carb_sulfotrans_8-10.
DR   InterPro; IPR005331; Sulfotransferase.
DR   PANTHER; PTHR12137; PTHR12137; 1.
DR   Pfam; PF03567; Sulfotransfer_2; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome; Disease mutation;
KW   Ehlers-Danlos syndrome; Glycoprotein; Golgi apparatus; Membrane;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    376       Carbohydrate sulfotransferase 14.
FT                                /FTId=PRO_0000189672.
FT   TOPO_DOM      1     39       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     40     60       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     61    376       Lumenal. {ECO:0000255}.
FT   NP_BIND     155    161       PAPS. {ECO:0000250}.
FT   NP_BIND     213    221       PAPS. {ECO:0000250}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    368    368       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     135    135       R -> G (in EDSMC1; associated in a
FT                                complex allele with Q-137; results in
FT                                altered intracellular processing;
FT                                dbSNP:rs267606727).
FT                                {ECO:0000269|PubMed:20004762}.
FT                                /FTId=VAR_063754.
FT   VARIANT     137    137       L -> Q (in EDSMC1; associated in a
FT                                complex allele with G-135; results in
FT                                altered intracellular processing;
FT                                dbSNP:rs267606728).
FT                                {ECO:0000269|PubMed:20004762}.
FT                                /FTId=VAR_063755.
FT   VARIANT     213    213       R -> P (in EDSMC1; results in altered
FT                                intracellular processing;
FT                                dbSNP:rs121908257).
FT                                {ECO:0000269|PubMed:20004762}.
FT                                /FTId=VAR_063756.
FT   VARIANT     281    281       P -> L (in EDSMC1; loss of activity;
FT                                dbSNP:rs267606729).
FT                                {ECO:0000269|PubMed:20533528}.
FT                                /FTId=VAR_064555.
FT   VARIANT     289    289       C -> S (in EDSMC1; loss of activity;
FT                                dbSNP:rs267606731).
FT                                {ECO:0000269|PubMed:20533528}.
FT                                /FTId=VAR_064556.
FT   VARIANT     293    293       Y -> C (in EDSMC1; results in altered
FT                                intracellular processing; loss of
FT                                activity; dbSNP:rs121908258).
FT                                {ECO:0000269|PubMed:20004762,
FT                                ECO:0000269|PubMed:20533528}.
FT                                /FTId=VAR_063757.
FT   CONFLICT    195    195       R -> L (in Ref. 4; BAC11172).
FT                                {ECO:0000305}.
FT   CONFLICT    214    214       E -> D (in Ref. 4; BAC11172).
FT                                {ECO:0000305}.
SQ   SEQUENCE   376 AA;  42997 MW;  53BF537979260188 CRC64;
     MFPRPLTPLA APNGAEPLGR ALRRAPLGRA RAGLGGPPLL LPSMLMFAVI VASSGLLLMI
     ERGILAEMKP LPLHPPGREG TAWRGKAPKP GGLSLRAGDA DLQVRQDVRN RTLRAVCGQP
     GMPRDPWDLP VGQRRTLLRH ILVSDRYRFL YCYVPKVACS NWKRVMKVLA GVLDSVDVRL
     KMDHRSDLVF LADLRPEEIR YRLQHYFKFL FVREPLERLL SAYRNKFGEI REYQQRYGAE
     IVRRYRAGAG PSPAGDDVTF PEFLRYLVDE DPERMNEHWM PVYHLCQPCA VHYDFVGSYE
     RLEADANQVL EWVRAPPHVR FPARQAWYRP ASPESLHYHL CSAPRALLQD VLPKYILDFS
     LFAYPLPNVT KEACQQ
//
